atossatherapeutics.com (ATOS) Stock Quotes

Atossa Therapeutics (ATOS) is developing breast cancer therapies by optimizing biocomponent supply chains to ensure R&D stability. The brand maintains an impeccable reputation in oncology due to its scientific integrity. The price trend reflected below captured the indicator at 2.15. The company is currently implementing robotic screening systems to accelerate preclinical trials of new drugs targeting women's health diseases.

Market Price: Atossa Therapeutics (ATOS) for 07/04/2022 - 11/11/2026

Metric breakdowns and analytics for Atossa Therapeutics Inc (ATOS)

- stock quotes and analyst forecast:

Stock Price Atossa Therapeutics|ATOS - Analyst Consensus Forecast

- market capitalization details:

Market Valuation Atossa Therapeutics Inc|ATOS - Aggregate Business Value

- issuer book value statistics:

Net Assets per Single Share Atossa Therapeutics|ATOS - Total Stockholders' Equity|Market Value to Book Value Ratio atossatherapeutics.com|ATOS - Company Total Asset Base

- debt and solvency information:

- company profitability and valuation multiples indicators:

ATOS - Company Net Income|Expected Profit Atossa Therapeutics|ATOS - Company Value to Net Income|Projected Price to Earnings Atossa Therapeutics, Inc.|ATOS - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Atossa Therapeutics Inc|ATOS - Operating profit before deduction of amortization|Earnings per share for the last twelve months Atossa Therapeutics|ATOS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months atossatherapeutics.com|ATOS - Net earnings per share growth this year|Earnings growth forecast for next year Atossa Therapeutics

Comprehensive company analysis:ATOS Atossa Therapeutics

For Atossa Therapeutics (ATOS), the share price reflects market expectations regarding the success of clinical trials for breast cancer drugs. This metric is calculated as the ratio of the biotech's total market capitalization to the total number of issued shares, capturing the current investor consensus. The price action on this linear chart demonstrates the business revaluation process based on the prospects of FDA formula approval.

Who Atossa Therapeutics competes with